Bioavailability Study of 6 Mercaptopurine in Crohns Disease Patients

Study Title

Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients

Teva Identifier

C1/13/6MP-02

ClinicalTrials.gov Identifier

NCT00774982

Study Status

Completed

Trial Condition(s)

Crohns Disease

Interventions

Drug: Delayed Release 6 mercaptopurine | Drug: 6 Mercaptopurine

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
disease icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 50 Years

Trial Duration

12/01/2008 - 02/01/2009

Phase

Phase 1

Study Type

Interventional